Deaths From Breast Cancer Decreasing

October 07, 1997

In the past few years, the number of women dying from breast cancer declined almost five per cent, the largest short-term decrease since 1950, according to a recent paper in Cancer Prevention & Control.

"Physicians are now detecting smaller, localized tumors earlier," says Professor Judy-Anne Chapman, a biostatistician at U of T, the Henrietta Banting Breast Centre and Women's College Hospital, who oversaw the analytical review of 153 breast cancer studies.

Reviewing papers for the National Cancer Institute of Canada, Chapman and her associates looked at studies examining breast cancer rates, screening and treatment conducted over the past 50 years. Data from U.S. studies revealed the incidence of breast cancer between 1940 and 1982 increased one per cent each year. Between 1982 and 1987, the increase was about four per cent each year.

But while the incidence of breast cancer has increased, the number of women dying from breast cancer is decreasing. Between 1989 and 1992, the mortality rate declined 4.7 per cent. "Through screening methods, particularly mammography, breast cancer is being detected earlier," notes Chapman. "Earlier detection has improved the prognosis for survival.

"As more breast cancers are detected at an earlier stage, mortality rates should continue to decline," she says. "While mammography is recommended for Canadian women 50 to 69 years of age, public health decision-makers need to revisit the question of whether 40- to 49-year-old women would also benefit from breast cancer screening."

Chapman notes that a review of data from the past 50 years needs to take into account the following cohort effects: women aged 40 to 49 more than 20 years ago have a relatively lower risk of breast cancer compared to current and future cohorts of 40- to 49-year-old women. This is due to that fact that fewer women 20 years ago were never pregnant, they tended to have their first pregnancy earlier and they had more pregnancies. In comparison, women currently 40 to 49 years of age may be at a higher risk of breast cancer because more of them have never been pregnant and there is a greater tendency to delay the first pregnancy and have fewer pregnancies.

The data analysis also revealed physicians play a key role in mammography. "Ninety-three to 94 per cent of women will comply with a physician's request to have a mammogram," says Chapman. The paper's investigators were funded by the National Cancer Institute of Canada and the Canadian Cancer Society. CONTACT: Professor Judy-Anne Chapman, department of public health sciences, (519) 579-2996, e-mail: jachapma@utstat.toronto.edu or Christina Marshall, U of T public affairs, (416) 978-5949, e-mail: christina.marshall@utoronto.ca

University of Toronto

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.